Shire plc (LON:SHP) Analyst Ratings as of May 3, 2018

May 3, 2018 - By Daniel Cummings

Shire plc (LON:SHP) Corporate Logo

Shire plc (LON:SHP) Ratings Coverage

Total analysts of 18 have positions in Shire PLC (LON:SHP) as follows: 14 rated it a “Buy”, 0 with “Sell” and 4 with “Hold”. The positive are 78%. Since November 6, 2017 according to StockzIntelligence Inc Shire PLC has 65 analyst reports. On Friday, November 17 the rating was maintained by RBC Capital Markets with “Outperform”. On Thursday, March 22 the stock of Shire plc (LON:SHP) has “Outperform” rating given by BNP Paribas. On Tuesday, March 27 the firm has “Overweight” rating by Morgan Stanley given. In Thursday, February 15 report Morgan Stanley maintained the stock with “Overweight” rating. On Tuesday, April 3 HSBC maintained Shire plc (LON:SHP) with “Hold” rating. In Wednesday, January 10 report JP Morgan maintained the stock with “Overweight” rating. On Friday, February 23 the company was maintained by Shore Capital. The company rating was maintained by Morgan Stanley on Friday, December 1. On Wednesday, November 29 the firm has “Buy” rating by Societe Generale given. On Friday, November 17 the stock of Shire plc (LON:SHP) earned “Buy” rating by Liberum Capital. Listed here are Shire plc (LON:SHP) PTs and latest ratings.

27/04/2018 Broker: Kepler Cheuvreux Rating: Buy Old Target: GBX 4250.00 New Target: GBX 4250.00 Maintain
26/04/2018 Broker: Deutsche Bank Rating: Buy Old Target: GBX 3559.00 Maintain
25/04/2018 Broker: RBC Capital Markets Rating: Outperform Maintain
25/04/2018 Broker: Shore Capital Rating: Buy Old Target: GBX 3607.00 New Target: GBX 4025.00 Maintain
25/04/2018 Broker: Liberum Capital Rating: Hold Old Target: GBX 4000.00 New Target: GBX 4000.00 Maintain
17/04/2018 Broker: RBC Capital Markets Rating: Outperform Maintain
17/04/2018 Broker: Deutsche Bank Rating: Buy New Target: GBX 3559.00 Maintain
16/04/2018 Broker: Liberum Capital Rating: Hold Old Target: GBX 4000.00 New Target: GBX 4000.00 Maintain
16/04/2018 Broker: Shore Capital Rating: Buy New Target: GBX 3607.00 Maintain
09/04/2018 Broker: BNP Paribas Rating: Outperform Old Target: GBX 4700.00 New Target: GBX 4700.00 Maintain

Ticker’s shares touched GBX 3843 during the last trading session after 1.32% change.Shire plc has volume of 2.79 million shares. Since May 3, 2017 SHP has 0.00% and is . SHP underperformed by 11.55% the S&P500.

Shire plc, a biotechnology company, focused on serving people with rare diseases and other specialized conditions worldwide.The company has 34.83 billion GBP market cap. The firm offers products in therapeutic areas, including hematology, genetic diseases, neuroscience, immunology, internal medicine, ophthalmology, and oncology.8.21 is the P/E ratio. The Company’s marketed products include ADVATE and ADYNOVATE/ADYNOVI for hemophilia A; RIXUBIS to treat hemophilia B; VONVENDI for the treatment of von willebrand Disease; FEIBA to treat hemophilia A and B patients with inhibitors; CINRYZE and FIRAZYR for hereditary angioedema; ELAPRASE to treat hunter syndrome; REPLAGAL for Fabry disease; and VPRIV to treat type 1 Gaucher disease.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: